QL
SGMT icon

Quarry LP’s Sagimet Biosciences SGMT Stock Holding History

Quarry LP’s Portfolio SGMT Stock Details SGMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$989 Buy
+128
New +$870 ﹤0.01% 1974
2024
Q2 		– Sell
-2,500
Closed -$13.6K – 2066
2024
Q1 		$13.6K Buy
+2,500
New +$18K ﹤0.01% 1093

Other funds holding SGMT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Quarry LP's SGMT Position: Q2 2026 in Review

Quarry LP opened a new position in Sagimet Biosciences (SGMT) in Q2 2026: 128 shares worth $989. The stake represents ﹤0.01% of the portfolio and ranks #1974 among its holdings. This is a return to the name: Quarry LP previously reported a position in SGMT as recently as Q1 2024.

Quarry LP first reported a position in SGMT in Q1 2024 and has held it in 2 quarters since. The position peaked at $13.6K in Q1 2024. 122 funds tracked by Wall St. Rank hold SGMT as of Q2 2026.

  • Quarry LP held 128 shares of Sagimet Biosciences worth $989 as of Q2 2026.
  • Sagimet Biosciences was a new Quarry LP position in Q2 2026.
  • Sagimet Biosciences made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #1974 holding.
  • Quarry LP first reported a position in Sagimet Biosciences in Q1 2024 and has held it in 2 quarters since.
  • Quarry LP's Sagimet Biosciences position peaked at $13.6K in Q1 2024.
  • 122 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.